Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park bld 800, Derio, Bizkaia 48160, Spain.
Ikerbasque, Basque Foundation for Science, Euskadi Plaza 5, 48009, Bilbao, Spain.
Glycobiology. 2024 Apr 1;34(3). doi: 10.1093/glycob/cwae002.
CD14 is an innate immune receptor that senses pathogen-associated molecular patterns, such as lipopolysaccharide, to activate the innate immune response. Although CD14 is known to be glycosylated, detailed understanding about the structural and functional significance of this modification is still missing. Herein, an NMR and MS-based study, assisted by MD simulations, has provided a 3D-structural model of glycosylated CD14. Our results reveal the existence of a key N-glycosylation site at Asn282 that exclusively contains unprocessed oligomannnose N-glycans that perfectly fit the concave cavity of the bent-solenoid shaped protein. This site is not accessible to glycosidases and is fundamental for protein folding and secretion. A second N-site at Asn151 displays mostly complex N-glycans, with the typical terminal epitopes of the host cell-line expression system (i.e. βGal, α2,3 and α2,6 sialylated βGal, here), but also particularities, such as the lack of core fucosylation. The glycan at this site points outside the protein surface, resulting in N-glycoforms fully exposed and available for interactions with lectins. In fact, NMR experiments show that galectin-4, proposed as a binder of CD14 on monocytes to induce their differentiation into macrophages-like cells, interacts in vitro with CD14 through the recognition of the terminal glycoepitopes on Asn151. This work provides key information about CD14 glycosylation, which helps to better understand its functional roles and significance. Although protein glycosylation is known to be dynamic and influenced by many factors, some of the features found herein (presence of unprocessed N-glycans and lack of core Fuc) are likely to be protein specific.
CD14 是一种先天免疫受体,可识别病原体相关分子模式,如脂多糖,从而激活先天免疫反应。虽然已知 CD14 发生糖基化,但对该修饰的结构和功能意义仍缺乏详细了解。在此,我们通过 NMR 和 MS 研究,并辅助 MD 模拟,提供了糖基化 CD14 的 3D 结构模型。结果表明,在 Asn282 存在一个关键的 N-糖基化位点,该位点仅含有未加工的寡甘露糖 N-聚糖,与弯曲螺线管形状的蛋白的凹腔完美匹配。该位点不易被糖苷酶作用,对蛋白折叠和分泌至关重要。第二个 N-位点位于 Asn151,主要含有复杂的 N-聚糖,具有宿主细胞系表达系统的典型末端表位(即βGal、α2,3 和 α2,6 唾液酸化的βGal),但也有一些特殊性,如缺乏核心岩藻糖基化。该位点的聚糖指向蛋白表面之外,导致 N-糖型完全暴露,并可与凝集素相互作用。事实上,NMR 实验表明,半乳糖凝集素-4 被认为是单核细胞上 CD14 的结合物,可诱导其分化为巨噬细胞样细胞,通过识别 Asn151 上的末端糖基表位,在体外与 CD14 相互作用。这项工作提供了有关 CD14 糖基化的关键信息,有助于更好地理解其功能作用和意义。虽然已知蛋白质糖基化是动态的,并受许多因素影响,但在此发现的一些特征(存在未加工的 N-聚糖和缺乏核心 Fuc)可能是蛋白特异性的。